Group 1 - The company, Brother Technology, has reported a recent increase in the price of Vitamin B1 products [1] - The company advises investors to monitor professional websites such as Boya Hexun for specific price information [1] - The company will closely observe industry trends and actively respond to national policies [1]

Investment Rating - The report maintains a recommendation for the chemical industry, indicating a positive outlook for the sector [7]. Core Insights - The report highlights significant price increases in TDI and Vitamin D3, suggesting a focus on the TDI and organic silicon sectors [1][5]. - The chemical sector outperformed the market, with a weekly increase of 1.77%, surpassing the Shanghai A-share index by 1.08 percentage points [2][15]. - Key stocks that performed well include Dongcai Technology (+33.16%) and Cangzhou Dahua (+28.47%), while stocks like Guangxin Materials (-9.26%) and Ando A (-9.05%) saw declines [2][15]. Industry Performance - In the third week of July, 20 sub-industries within the chemical sector saw increases, with the top five being modified plastics (+7.42%) and phosphate chemicals (+7.41%) [3][19]. - The dynamic PE ratio for the chemical sector is reported at 25.83 times, which is lower than the average PE of 30.02 times since 2015 [2][15]. Price and Spread Trends - The report lists the top five products with the highest weekly price increases: liquid chlorine (+21.78%), TDI (+18.83%), and Vitamin D3 (+10%) [4][22]. - The report also notes significant changes in price spreads, with the ethylene spread increasing by 81.82% and PTA spread decreasing by 357.81% [4][43]. Inventory Changes - Notable inventory changes include an increase in epoxy propane (+11.97%) and a decrease in ethylene (-8.57%) [5][61]. Recommendations - The report suggests monitoring companies such as Cangzhou Dahua and Wanhua Chemical due to the significant rise in TDI prices [5]. - Attention is also drawn to organic silicon producers like Xin'an Chemical and Xinfeng Group, following a fire incident affecting supply [5].

Group 1: Chemical Sector Performance - The chemical index and oil index experienced a comprehensive increase last week, with the chemical raw materials index rising by 1.50%, the chemical machinery index by 3.96%, the chemical pharmaceuticals index by 2.46%, and the pesticide and fertilizer index by 1.29% [1] - The top five rising petrochemical products included Vitamin B1, which increased by 12.82%, Vitamin D3 by 7.14%, and toluene diisocyanate by 4.47%, while the top five declining products included liquid chlorine, which fell by 48.51%, and hydrochloric acid by 8.29% [1] Group 2: Oil Sector Performance - International crude oil prices continued a strong trend, with WTI settling at $68.45 per barrel, up 2.16% from July 3, and Brent at $70.36 per barrel, up 3.02% from July 4 [1] - The oil processing index rose by 0.52%, the oil extraction index by 0.88%, and the oil trading index by 0.63% [1] Group 3: Capital Market Performance of Chemical Companies - The top five rising listed chemical companies in the capital market included Shangwei New Materials, which surged by 72.88%, and Hongbo New Materials, which rose by 24.726% [2] - The top five declining listed chemical companies included Ruilian New Materials, which fell by 15.98%, and Xingye Co., which dropped by 9.08% [2]

Investment Rating - The report maintains a recommendation for the chemical industry, indicating a positive outlook for the sector [5]. Core Views - The report highlights significant price increases in Vitamin B1 (+12.82%) and fatty alcohols (+8.16%), suggesting a focus on companies expected to show substantial quarter-over-quarter growth in Q2 [3][4]. - The overall chemical sector saw a 0.80% increase in the second week of July, lagging behind the Shanghai Composite Index, which rose by 1.40% [13]. - The dynamic PE ratio for the chemical sector is reported at 25.37 times, which is lower than the average PE of 6.89% since 2015 [13]. Industry Performance - In the second week of July, 23 sub-industries within the chemical sector experienced growth, while 9 sub-industries declined. The top five performing sub-industries included fiberglass (+8.73%) and synthetic leather (+8.34%) [17]. - The report notes that the chemical sector's performance is characterized by a mix of price increases and decreases across various products, with significant fluctuations in inventory levels for key products [50]. Price and Spread Trends - The report identifies the top five products with the highest price increases: Vitamin B1 (+12.82%), fatty alcohols (+8.16%), and dichloropropane (+8.11%) [22]. - Conversely, the largest price declines were seen in liquid chlorine (-48.51%) and hydrochloric acid (-8.29%) [22]. - The report also highlights significant changes in price spreads, with ethylene spreads increasing by 816.67% [32]. Inventory Changes - Notable inventory changes include a 15.88% increase in polyester filament and a 10.08% increase in polyester chips [50].

Industry Investment Rating - The industry investment rating is "Outperform" [2] Core Views - The report emphasizes the importance of addressing "involution" in the industry, focusing on sectors such as silicon materials, coal chemicals, and chlor-alkali chemicals. It highlights the need for companies to enhance product quality and manage low-price competition. Attention is drawn to performance and price increases in potassium fertilizers, phosphorus fertilizers, active dyes, and pesticides as the mid-year reporting period approaches [5][6]. Summary by Sections Industry Overview - The closing index for the basic chemical industry is at 3572.47, with a weekly high of 3587.1 and a low of 2687.54. The basic chemical sector has shown a weekly increase of 1.53%, outperforming the CSI 300 index, which increased by 0.82% [2][6]. Price Movements - Significant price increases were noted in products such as chick seedlings (30.68%), monocrystalline silicon wafers (16.28%), and vitamin B1 (12.82%). Conversely, liquid chlorine saw a substantial decrease of 48.51% [9][10][23][25]. Stock Performance - Notable stock performances included significant increases for companies like Upwind New Materials (72.88%) and Hongbai New Materials (24.72%). On the downside, companies like Ruile New Materials (-15.98%) and Guangkang Biochemical (-11.04%) experienced declines [7][8][21][22]. Key Companies and Ratings - Key companies in the report include: - Wanhua Chemical (Buy, closing price 54.1, market cap 169.83 billion) - Runfeng Co. (Not rated, closing price 56.0, market cap 15.71 billion) - Yara International (Not rated, closing price 30.1, market cap 27.83 billion) - Yangnong Chemical (Buy, closing price 58.1, market cap 23.56 billion) - Meihua Biological (Buy, closing price 11.1, market cap 31.52 billion) [12][13][14].

Investment Rating - The report maintains an "Overweight" rating for the basic chemical industry [1] Core Insights - The Central Financial Committee's sixth meeting emphasized the need to govern low-price disorderly competition legally and regulate the exit of backward production capacity, indicating a focus on improving product quality and sustainable industry development [4][28] - The basic chemical industry has seen a recent price increase in key products, with significant gains in certain sectors such as refrigerants, sweeteners, and organic silicon [4][30] Market Performance - As of July 10, 2025, the CITIC basic chemical industry index rose by 2.57% over the past two weeks, outperforming the CSI 300 index by 0.95 percentage points, ranking 14th among 30 CITIC industries [11] - Year-to-date, the basic chemical industry has increased by 9.67%, surpassing the CSI 300 index by 7.76 percentage points, ranking 11th [11] Chemical Product Price Trends - The top five products with the highest price increases recently include Vitamin B1 (+12.82%), fatty alcohol (+8.16%), dichloropropane-white material (+8.11%), Vitamin D3 (+7.14%), and paraquat (+6.56%) [21] - The top five products with the largest price declines include liquid chlorine (-48.51%), hydrochloric acid (-8.29%), butyl rubber (-7.79%), aniline (-6.05%), and calcium chloride (-5.06%) [21] Industry Subsector Highlights - The organic silicon sector has shown a recent increase of 11.11% over the past two weeks, indicating strong performance [17] - The refrigerant sector is expected to benefit from the accelerated reduction of second-generation refrigerant quotas and the continued freeze on third-generation quotas, with companies like Juhua Co. and Sanmei Co. projected to see significant profit increases [30][31] Company Announcements - Sanmei Co. expects a net profit of approximately 947.619 million to 1.042381 billion yuan for the first half of 2025, marking a year-on-year increase of 146.97% to 171.67% [31] - Juhua Co. anticipates a net profit of 1.97 billion to 2.13 billion yuan for the same period, reflecting a year-on-year increase of 136% to 155% [31]

Investment Rating - The investment rating for the company is maintained as "Buy" [2] Core Views - The prices of the main products, Vitamin B1 and B6, remain strong, contributing to profit growth. The company is a significant supplier in the global B vitamin market, holding leading market shares in Vitamin B6 and B1, with a revenue contribution of 78% from B vitamins in 2024. The prices for Vitamin B6 and B1 have shown year-on-year increases of 43.8% and 21.04% respectively in the first half of 2025, driving rapid profit growth [8][5] - The company is expanding its product line with new projects, including Vitamin B5 and Vitamin A, which are expected to enhance its long-term growth potential. The successful launch of these new products could significantly increase the company's market presence [8] - The financial forecast has been slightly adjusted, with expected net profits for 2025, 2026, and 2027 projected at 921 million, 1,063 million, and 1,070 million respectively. The corresponding PE ratios are estimated at 13, 11, and 11 times. The target market value for 2025 is set at 141 billion, indicating a 21% upside potential from the current market value [8][10] Financial Data and Profit Forecast - Total revenue is projected to grow from 2,209 million in 2024 to 2,708 million in 2025, with a year-on-year growth rate of 22.6%. The net profit is expected to increase from 651 million in 2024 to 921 million in 2025, reflecting a growth rate of 41.4% [7][12] - The gross margin is anticipated to improve from 42% in 2024 to 51.1% in 2025, while the return on equity (ROE) is expected to rise from 14.1% to 16.6% during the same period [7][12]